Načítá se...
Design, synthesis and evaluation of belinostat analogs as histone deacetylase inhibitors
AIM: Histone deacetylase (HDAC) is an attractive target for antitumor therapy. Therefore, the development of novel HDAC inhibitors is warranted. MATERIALS & METHODS: A series of HDAC inhibitors based on N-hydroxycinnamamide fragment was designed as the clinically used belinostat analog using ami...
Uloženo v:
| Vydáno v: | Future Med Chem |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Newlands Press Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7607388/ https://ncbi.nlm.nih.gov/pubmed/31702394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc-2018-0587 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|